Tackling complexity in BA/BE studies for Type-2 Diabetes and weight management. Syngene overcame high-dose tolerability issues, complex bioanalytical methods, and long PK studies with <5% drop-out across 800+ trials. Read more: https://t.co/5Qm75aRm6U

Syngene’s Chief Scientific Officer, Dr. Jayashree Aiyar, shares insights in European Pharmaceutical Manufacturer on how India’s CRDMO sector is shifting from cost-centric to value-driven, science-led growth. Read more: https://t.co/HxJNW88Gnm

“We were impressed with how streamlined their process is in getting you approved for purchasing and installing the system. And it’s pretty amazing that you no longer have to pay the utility company for your electricity because the system provides all the electric power you need

Choosing the right preclinical species is crucial for extended-release (ER) formulation success. Syngene optimized formulation, PK studies, and model selection—enhancing predictability, saving time, and enabling smooth clinical translation. Read more: https://t.co/5vsGyMX13N

Frustrated by tech-transfer delays or unclear updates? Partner with a CDMO built on transparency and predictability. At Syngene, seamless tech transfer and proactive communication keep your programs moving forward. Connect: https://t.co/tuZa9pLl5g

Syngene featured in BioSpectrum Asia! Dr. Kenneth Barr shares how AI, precision sciences, and translational insights are driving faster, smarter clinical trials. Read more: https://t.co/AIGwo7cUM7

1/ Welcome to Wall Street, @solana! As of the opening 🔔 today, $BSOL, offered by @BitwiseInvest, is now live on the @NYSE, and @Grayscale’s $GSOL will launch in the days ahead.

Syngene provides Nitrosamine Assessment services per FDA and EMA guidelines, including CPCA, metabolic stability with human hepatocytes, Enhanced Ames Test (GLP), and in vitro mammalian cell mutation assays (TK6, Hprt). Contact us: https://t.co/XmZksu47gS

#WeareHiring | Lead – Biostatistics & Clinical Data Management. If you’re passionate about biostatistics, clinical data excellence, and leading high-performing teams, this is your opportunity to make an impact. Location: Bangalore Apply now: https://t.co/CApbWXo6om

𝗝𝗼𝗶𝗻 𝘂𝘀 𝗮𝘁 𝗔𝗔𝗣𝗦 𝟮𝟬𝟮𝟱 𝗣𝗵𝗮𝗿𝗺𝗦𝗰𝗶 𝟯𝟲𝟬 Session: Critical Factors in Choosing Closure Systems for Frozen Biotherapeutics 𝗦𝗽𝗲𝗮𝗸𝗲𝗿: Purushottam, VP, Formulation Development 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟭𝟬, 𝟭𝟮:𝟯𝟬 𝗣𝗠 – 𝟭:𝟭𝟱 𝗣𝗠 | San Antonio, TX

Meet Syngene at CPHI Frankfurt, Booth # 6.0C66 | Oct 28–30, 2025. Explore end-to-end CRDMO solutions—from AI-driven discovery to global manufacturing—for small & large molecules, HPAPIs & biologics. Let’s innovate → https://t.co/hIRrjB3oAK #CPHIFrankfurt #CRDMO #Syngene

Purifying millions of gallons of water using small amounts of electricity, and our machines look like they belong either in Tomorrowland or a Christopher Nolan movie. ⚡️

Save up to four months in biologics development by starting Cell Line Development early — reducing risks and fast-tracking your molecule from gene to GMP. Register now: https://t.co/Hb4s2aqJie #Syngene #Biologics #mAb #CDMO #DrugDevelopment

Join us at Syngene Accelerator Award Day to explore early-stage biotech innovations and meet the minds shaping the future of drug discovery. https://t.co/fJXTdm5GZf #BiotechInnovation #SyngeneAccelerator #DrugDiscovery #Biopharma

Is your preclinical tox strategy built for success? Discover how strategic species selection, dose formulation, and integrated tox studies can fast-track IND readiness. Read insights from Mohan Krishnappa here: https://t.co/Qzd8nWS4Ws #DrugDevelopment #Toxicology #Syngene

Pharma Bio World features Syngene’s T&CR platform reshaping early drug dev with integrated discovery-to-clinic insights. Read more: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/ https://t.co/b1bb0ppPOJ #Syngene #TnCR #ClinicalResearch #DrugDevelopment #GeneTherapies

We asked people in Times Square what it felt like to have a hacker reveal their private info. See how they reacted in the video!

Scale your success with Syngene’s cGMP-compliant commercial manufacturing solutions. From small molecules to HPAPIs & advanced intermediates, our state-of-the-art facilities ensure flexibility, quality & speed. Contact us: https://t.co/tuZa9pLl5g #HPAPI #CDMO

India powers global healthcare—20% of generics, 80% of antiretrovirals. With https://t.co/nkYwxicqa6™ & SARchitect™, Syngene is redefining R&D. Read more https://t.co/EpBlHYPbRj Contact us https://t.co/tuZa9pLl5g #PharmaInnovation #AIinPharma #IndiaBiotech

SynVent bridges global science with local impact. Led by Dr. Gagan Kukreja, our India-Europe teams drive collaborative drug discovery for complex challenges. 👉 https://t.co/aZX33j9cp7 #SynVent #DrugDiscovery

Accelerate preclinical research with Syngene’s GLP-compliant pathology expertise—precision, speed & regulatory readiness. 👉 https://t.co/tuZa9pLl5g #PathologyServices #PreclinicalResearch

THE NARSSICA NOVEL Delphine Devereaux looks perfect. She's not. Delphine Devereaux is the daughter of a controversial movie star and a genius inventor who created metaliester - a miracle fabric lighter than silk, stronger than steel. When both parents vanished, they left her

From NCEs to clinical trials, Syngene’s formulation development expertise ensures first-time-right execution. End-to-end services cut delays & accelerate delivery with quality at every step. Learn more → https://t.co/tuZa9pLl5g #PharmaSolutions #cGMP

DMPK Unravelled Webinar Series – Ep 3 Topical Drug Delivery: From Preclinical Promise to Clinical Precision Speakers: Miquel Salvà (Synvent), Ashwani Gaur (Syngene) | Chair: Dr. Vishwottam Kandikere 📅 Register: https://t.co/q5wM5XFV0X #Syngene #DMPK #Webinar

Grow your career with purpose at one of the world’s most sustainable CRDMOs. At Syngene, we unite responsibility with innovation—shaping the future of science while shaping your own. Explore careers → https://t.co/NKJcBNxLzv #SyngeneCareers #ScienceWithPurpose #WeAreHiring